As of 2025-05-27, the Fair Value of ADiTx Therapeutics Inc (ADTX) is -59.97 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.74 USD, the upside of ADiTx Therapeutics Inc is -3,546.44%.
With the market price of 1.74 USD and our fair value calculation, ADiTx Therapeutics Inc (ADTX) is not a good investment. Investing in ADTX stocks now will result in a potential loss of 3,546.44%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -9.15 | -46.37 | -27.65 | -32.38 | -34.45 | -30.00 |
| YoY growth | -56.95% | -406.78% | 40.37% | -17.11% | -6.38% | -89.37% |
| Market Cap (mil) | 3.69 |
| P/E | |
| Forward P/E |
| EPS | -11.99 |
| Avg earnings growth rate | -89.37% |
| TTM earnings | -25.43 |